SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals more than 18,000, including physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from 76 countries around the world.
SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals over 18,000, which includes physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from more than 75 countries around the world. SNMMI's Journal of Nuclear Medicine (JNM), the premier international journal of nuclear medicine, reaches over 18,000 individuals each month. SNMMI's Annual Meeting is nuclear medicine's and molecular iamging's largest gathering each year, attracting over 4,000 professional attendees and another 2,500 industry representatives.
At the most recent Annual Meeting in June 2013 in Vancouver, BC, Canada, 38% of registered attendees were from countries other than the United States. Attendees represented over 69 countries. In addition, abstract submissions for SNMMI's Annual Meeting from outside the United States represent close to 65% of all submissions.
While SNMMI's headquarters office resides in Virginia, just outside of Washington, D.C., its perspective, programs, and growth are as international as its members. As of 2013, more than 11.8% of the Society's members reside in more than 75 countries other than the United States.
Search for an international nuclear medicine and molecular imaging organization near you.
SNMMI's educational programs and activities reflect the increasing importance and participation of its international members. Such common global nuclear medicine and molecular imaging and therapy issues as quality of care, educating referring physicians and patients, and exploring ways to better share developments in the practice of nuclear medicine and molecular imaging and therapy are but a few of the activities currently underway by Society staff, Committees, Councils, and our Centers of Excellence. This website seeks to constantly expand its offerings to the Society's international members, providing an ever-changing, updated array of global resources and news for nuclear medicine and molecular imaging and therapy professionals literally anywhere on the globe.
SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting. These joint sponsored programs include not only the sharing of speakers and renown experts on all facets of nuclear medicine and molecular imaging, collaboration on the development of enduring educational materials, and programmatic/administrative support, but also include translation of materials and website development.
Each year, the SNMMI collaborates with international organizations in an effort to continue the exchange of ideas, education and knowledge. Intiatives include:
Nuclear Medicine Global Initiative
3rd Sino-American Conference
Chinese/U.S. Resident Exchange Program
IAEA CT Case Webinar Series
EANM Collaborative Guidelines
SNMMI 2015 Annual Meeting | 6-10 June 2015 | Baltimore, Maryland, USA
The SNMMI Annual Meeting has been recognized by thousands of professional attendees from across the globe as the premier educational and networking event in molecular imaging and nuclear medicine. The 2015 Annual Meeting will continue to build on past successes offering: the latest educational content; virtual learning opportunities both during the meeting and post-conference; networking events; and an exhibit hall packed with the latest technology.
AACR-SNMMI Joint Conference on State of the Art: Molecular Imaging in Cancer Biology and Therapy | 11-14 February 2015 | San Diego, California, USA
This joint meeting between the AACR and the Society of Nuclear Medicine and Molecular Imaging will bring together imaging scientists with biologists in basic, translational, and clinical research to explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes.
3rd Theranostics World Congress (3TWC) on Ga-68 and PRRT | 12-14 March 2015 | Baltimore, Maryland, USA
This conference will provide updates on recent developments in the exciting field of Theranostics for NETs, prostate, and beyond. A team of experts from around the world will discuss their research and experience in this exciting field.
SNMMI offers a Full International Membership category for inernational colleagues. Learn more on how to become an SNMMI Full Member (international).
Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine. This includes the diagnostic, therapeutic or investigational use of radionuclides or other molecular imaging technologies.
Annual dues: $460
Includes subscription to The Journal of Nuclear Medicine.
Includes voting rights and can be elected an Officer of the SNMMI.
As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States. These strategic alliances stretch across the globe. reaching every continent where SNMMI's members reside and practice.
SNMMI Partners and Alliances Include:
For more information on SNMMI's international activities and programs, please contact:
Nikki Wenzel-Lamb, MBA Director of Leadership Direct: 703-652-6766 Fax: 703-708-9020 Email: email@example.com
SNMMI and ERF are pleased to announce that David Douglas, MD and Benjamin Franc, MD are the recipients of the 2015 Robert E. Henkin Fellowship.
(Government Relations News)
Using a battery of imaging and cognitive tests, Johns Hopkins specialists have gathered evidence of accumulated brain damage that may be linked to specific memory deficits experienced by former National Football League players decades after retirement.
(MI: Making a Difference)
New research from Johns Hopkins School of Medicine reveals a high value for scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer.
(MI: Making a Difference)
By showing how four or more follow-up FDG-PET/CT scans for lung cancer can alter patient treatment plans, researchers at Johns Hopkins University are making the case for expanded Medicare reimbursement for these exams in a new article in the February edition of the Journal of Nuclear Medicine.
(MI: Making a Difference)
This congress—co-sponsored by SNMMI and Johns Hopkins Medicine—will provide updates on recent developments in the field of Theranostics for NETs, Prostate Cancer, and beyond. Experts from around the world will discuss their research and experience in this exciting field.
Register by 30 January 2015 and save $100USD
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.